Andrew McLean‐Tooke

Author

Andrew McLean‐Tooke

Also Known As

A McLean-Tooke, A McLean‐Tooke, A Mclean-Tooke, A. McLean-Tooke, A. McLean‐Tooke, A. Mclean-Tooke, A. P. C. MCLEAN‐TOOKE, Andrew Martin, Andrew McLean Tooke, Andrew McLean-Tooke

104

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Sir Charles Gairdner Hospital Pathwest Laboratory Medicine The University of Western Australia Royal Victoria Infirmary Princess Margaret Hospital for Children

About

Andrew McLean‐Tooke is an author at Sir Charles Gairdner Hospital specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	513
2	Allergy	5	5	234
3	Health Sciences	1	1	21
4	Public Health	1	1	10
5	Biostatistics	1	1	10

Andrew McLean‐Tooke

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes Ulrich Salzer, Chiara Bacchelli, Sylvie Buckridge, Blood	2008	274
Mutations in <i>CHD7</i> in patients with CHARGE syndrome cause T–B + natural killer cell + severe combined immune deficiency and may cause Omenn-like syndrome Andrew R. Gennery, Mary Slatter, Jason Rice, Clinical & Experimental Immunology ImmunodeficienciesImmunologyPathologyImmunotherapyImmune Dysregulation	2008	119
Immunologic defects in 22q11.2 deletion syndrome Andrew McLean‐Tooke, D Barge, Gavin P Spickett, Journal of Allergy and Clinical Immunology Primary ImmunodeficiencyAutoimmune DiseaseImmunodeficienciesImmunologyPathology	2008	91
Anti‐tissue transglutaminase antibodies in the follow‐up of adult coeliac disease Chris R. Dipper, Sohom Maitra, Reena Thomas, Alimentary Pharmacology & Therapeutics	2009	69
The revolving door: antibiotic allergy labelling in a tertiary care centre Božidarka Knežević, D. Sprigg, Jason Seet, Internal Medicine Journal	2016	68
Postmortem serum tryptase levels in anaphylactic and non-anaphylactic deaths Andrew McLean‐Tooke, Mark Goulding, Christine Bundell, Journal of Clinical Pathology	2013	64
Diagnostic performance of a commercial immunoblot assay for myositis antibody testing Chris Bundell, Arada Rojana-udomsart, Frank Mastaglia, Pathology ImmunohematologyMyositis AntibodyAllergyAutoimmune DiseaseImmunology	2016	54
Diversity of XMEN Disease: Description of 2 Novel Variants and Analysis of the Lymphocyte Phenotype Elizabeth Klinken, Paul Gray, Bethany Pillay, Journal of Clinical Immunology Lymphoid NeoplasiaImmunogeneticsXenotransplantationAutoimmune DiseaseNovel Variants	2019	34
Fulminant Anti-GAD antibody encephalitis presenting with status epilepticus requiring aggressive immunosuppression James Triplett, Srimathy Vijayan, Allycia MacDonald, Journal of Neuroimmunology Aggressive ImmunosuppressionAutoimmune DiseaseMedicineImmunologyStatus Epilepticus	2018	31
Increasing recognition of dermatomyositis with subcutaneous edema – is this a poorer prognostic marker? Jenny Tu, Andrew McLean‐Tooke, Reimar Junckerstorff Dermatology Online Journal RheumatologyPoorer Prognostic MarkerHistopathologyDiagnosisPathology	2014	28

Page 1